We are live on
!
Find out more
Bristol-Myers Squibb
BMY
BMY
2,331 hedge funds and large institutions have $84.5B invested in Bristol-Myers Squibb in 2024 Q1 according to their latest regulatory filings, with 172 funds opening new positions, 934 increasing their positions, 967 reducing their positions, and 178 closing their positions.
New
Increased
Maintained
Reduced
Closed
26% more call options, than puts
Call options by funds: $1.56B | Put options by funds: $1.23B
4% more capital invested
Capital invested by funds: $81.1B → $84.5B (+$3.44B)
0.56% less ownership
Funds ownership: 77.65% → 77.09% (-0.56%)
3% less first-time investments, than exits
New positions opened: 172 | Existing positions closed: 178
3% less repeat investments, than reductions
Existing positions increased: 934 | Existing positions reduced: 967
1% less funds holding
Funds holding: 2,363 → 2,331 (-32)
17% less funds holding in top 10
Funds holding in top 10: 24 → 20 (-4)
Holders
2,331
Holders Change
-32
Holders Change %
-1.35%
% of All Funds
33.58%
Holding in Top 10
20
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-16.67%
% of All Funds
0.29%
New
172
Increased
934
Reduced
967
Closed
178
Calls
$1.56B
Puts
$1.23B
Net Calls
+$326M
Net Calls Change
-$171M
Top Buyers
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$1.5B |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$616M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$407M |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
-$329M |
| 5 |
BlackRock
New York
|
-$282M |
